OB
Oxford Bioscience Partners
Micro VCActiveOxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides equity financing and management assistance
110
Investments
7
Exits
$1.2B
AUM
6.4%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Oxford Bioscience Partners.
Investment Thesis & Strategy
Oxford Bioscience Partners invests in biotech and healthcare companies across various stages, providing both capital and management assistance to help them grow.
Investment Activity
Deals per year over the last 6 years
1
20030
20040
20051
20062
20071
2008Portfolio Companies
Selected investments from their portfolio of 110 companies
M
Millennium Pharmaceuticals
Biotech · Growth, 0
A
Acorda Therapeutics
Biotech · Growth, 0
A
Alkermes
Biotech · Growth, 0
N
Neurocrine Biosciences
Biotech · Growth, 0
B
Biogen
Biotech · Growth, 0
C
Cubist Pharmaceuticals
Biotech · Growth, 0
I
Ironwood Pharmaceuticals
Biotech · Growth, 0
E
Esperion Therapeutics
Biotech · Growth, 2008
E
Epizyme
Biotech · Series A, 2007
C
Concert Pharmaceuticals
Biotech · Series A, 2007
C
Celator Pharmaceuticals
Biotech · Series A, 2006
A
Acceleron Pharma
Biotech · Growth, 2003
Notable Exits
CompanyTypeYearValue / Acquirer
Acceleron PharmaAcquisition2021$11.5B
Portola PharmaceuticalsAcquisition2019$1.2B
Cubist PharmaceuticalsAcquisition2014$8.4B
Esperion TherapeuticsIPO2013—
Millennium PharmaceuticalsAcquisition2008$8.9B
Sirna TherapeuticsAcquisition2006$550M
Arris PharmaceuticalAcquisition2004$230M
Frequently Asked Questions
Oxford Bioscience Partners focuses on Seed, Series A stage investments.